Side Effects: Progress, with Asterisks

• by Kerri Miller

• May 6, 2026

Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults

• by Charlotte E. Joslin, Angie Wang, David J. Lee, Lawrence J. Ulanski, Byron L. Lam, Thasarat S. Vajaranant, Carlos E. Mendoza-Santiesteban, Michael L. Stewart, Giselle Gutierrez Savoy, Mehmet Cem Mocan, Franklyn Gonzalez, D. Diane Zheng, Bharat Thyagarajan, Laura Coco, Amber Pirzada, Jianwen Cai, Martha L. Daviglus, SOL Ojos Study Group, Giselle A. Gutierrez Savoy, Heather Pauls Hrynyk, Angie Wang, Raiza Perez Lucena, Chunyu Guo, Evelyn Ramirez, Patrizia A. Chavero, Lucila Suarez, Banelly Mora, Sydney Tobias, Manishi A. Desai, Pathik P. Amin, Hannah Yoon, Charles W. Kinnaird, Ramón A. Durazo-Arvizu, Margaret Weiss, Norma Del Risco, David J. Lee, Stephanie Negron, Byron Lam, Diane Zheng, Neil Schneiderman, Laura A. McClure, Miguel Valladares Regalado, Tamara Juvier-Riesgo, Liliana Rosello-Rodriguez, Estefania Ruano-Herreria, Maia Junco, Diana Hernandez Payano, Richard Ramos, Eliseo Moreno Perez, Maria Cristina Buhl, Jianwen Cai, Franklyn Gonzales , Marston Youngblood Jr., Maryann Redford, Jimmy T. Le, Karla Zadnik, Juan E. Grunwald, Henry D. Jampel, Aracely Rosales , Brisa N. Sánchez, Sheila K. West, Siew Wei Gavin Tan, Yi Chong Teo, Haslina Hamzah, Shu Chin Serene Sim, Amalia Juhari, Muhamad Asri Abdul Kadir, Raudhah Hanim Mohamed Yusof, Xingxiu Ho, Jinyi Ho, Nishal Banu Makdoom, Kayathri Jaya Paul, Sharifah Athirah Diba Sagoff

• June 12, 2026

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.

• by Andrea Surnit

• June 15, 2026

• 4 min

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

• by Kathryn Wighton

• June 22, 2026

• 3 min